Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26492210 | 0.96 | CASP3 (0.41) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL17932120 | 0.96 | CASP3 (0.41) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL17932130 | 0.94 | PLA2G2A (0.43) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL17945569 | 0.94 | PLA2G2A (0.43) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL17945562 | 0.92 | TDP1 (0.43) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL17932149 | 0.92 | GPR84 (0.38) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL22908269 | 0.92 | GPR84 (0.38) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL26492208 | 0.92 | HDAC4 (0.38) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL23502218 | 0.91 | TDP1 (0.40) | CASP3SENP7SENP6TDP1L3MBTL1 | |
| SCHEMBL23502253 | 0.91 | TDP1 (0.40) | CASP3SENP7SENP6TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024096410-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2024-05-10 | — | — | WO | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| WO-2023190597-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | 出光興産株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-4245743-A1 | METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION | Lg Chem, Ltd. (KR) | 2023-09-20 | — | — | EP | disclosed |
| WO-2023172110-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-09-14 | — | — | WO | disclosed |
| WO-2022169218-A1 | METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION | 주식회사 엘지화학 | 2022-08-11 | — | — | WO | disclosed |
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-21 | — | — | US | disclosed |
| US-9691990-B2 | Compound, organic electronic element using same, and electronic device using the latter | DUK SAN NEOLUX CO., LTD. (KR) | 2017-06-27 | — | — | US | disclosed |
| US-20160218297-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| US-20160218297-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | OR10J3, OR51E2, LOXL1 | CASP3 4345/4885SENP7 3813/4885SENP6 4365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.